Videos
Leukemia
Tanios Bekaii-Saab, MD, discusses the results from the phase III BEACON CRC study; investigators evaluated the efficacy and safety of triplet encorafenib, binimetinib, and cetuximab in patients with BRAF V600E–mutant metastatic colorectal cancer who previously received up to 2 lines of prior therapy.
Chronic Myeloid Leukemia
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Beyond SC Daratumumab: Emerging Therapeutic Approaches for Smoldering Myeloma
2
Poll: Vote on the Top Abstracts to Watch at SABCS 2025
3
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
4
MVR-T3011 Yields Efficacy and Safety in BCG-Unresponsive NMIBC
5
